GSK plc (LON:GSK) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of GSK plc (LON:GSK) have been given a consensus recommendation of “Moderate Buy” by the seven analysts that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating and five have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is GBX 1,842.50 ($23.20).

Several research analysts have commented on the stock. Berenberg Bank reissued a “buy” rating and set a GBX 1,820 ($22.92) price target on shares of GSK in a research note on Tuesday, September 10th. Deutsche Bank Aktiengesellschaft restated a “buy” rating and set a GBX 1,850 ($23.30) target price on shares of GSK in a report on Tuesday, September 3rd. JPMorgan Chase & Co. reaffirmed an “underweight” rating on shares of GSK in a research note on Monday, July 29th. Finally, Shore Capital reiterated a “buy” rating on shares of GSK in a research report on Wednesday, August 28th.

GSK Stock Up 1.2 %

Shares of LON:GSK opened at GBX 1,325 ($16.69) on Monday. The company has a market cap of £54.06 billion, a price-to-earnings ratio of 1,172.57, a PEG ratio of 1.24 and a beta of 0.31. GSK has a one year low of GBX 1,282.50 ($16.15) and a one year high of GBX 1,823.50 ($22.96). The firm has a fifty day moving average price of GBX 1,460.77 and a two-hundred day moving average price of GBX 1,564.08. The company has a debt-to-equity ratio of 123.04, a current ratio of 0.82 and a quick ratio of 0.73.

GSK Dividend Announcement

The firm also recently announced a dividend, which will be paid on Thursday, January 9th. Shareholders of record on Thursday, November 14th will be paid a dividend of GBX 15 ($0.19) per share. This represents a dividend yield of 1.03%. The ex-dividend date of this dividend is Thursday, November 14th. GSK’s dividend payout ratio is 5,309.73%.

Insider Activity at GSK

In other news, insider Jonathan Symonds purchased 7,150 shares of GSK stock in a transaction that occurred on Wednesday, October 30th. The stock was bought at an average price of GBX 1,394 ($17.55) per share, with a total value of £99,671 ($125,514.42). Also, insider Elizabeth (Liz) McKee Anderson bought 446 shares of the business’s stock in a transaction on Monday, September 23rd. The shares were acquired at an average price of GBX 2,051 ($25.83) per share, for a total transaction of £9,147.46 ($11,519.28). Insiders purchased a total of 7,604 shares of company stock valued at $10,893,038 in the last 90 days. Corporate insiders own 1.61% of the company’s stock.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.